Swiss Re has collaborated with composite insurer Earnings Insurance coverage to launch a most cancers insurance coverage product in Singapore.

Known as Full Most cancers Care, the brand new product is designed to supply steady care and monetary help to these recognized with most cancers.

Swiss Re mentioned that the product will supply a “assured” post-cancer protection different for purchasers with out requiring a prerequisite well being evaluation, even after a most cancers prognosis.

Along with normal choices, which principally centre round lump sum funds after prognosis, the answer focuses on offering help for most cancers sufferers who’re receiving therapy with month-to-month payouts and a premium waiver profit.

Moreover, Full Most cancers Care offers a hospice care profit to help sufferers receiving palliative care.

The product helps an entry age of as much as 74 years outdated, with protection to a most age of 84 years outdated to cater to Singapore’s ageing inhabitants.

Swiss Re head of life and well being reinsurance APAC ex China Daisy Ning mentioned: “The launch of Full Most cancers Care demonstrates our dedication to supporting policyholders of their time of want by enabling our companions as they innovate and adapt to evolving buyer wants.

“We’re dedicated to serving to insurers tailor complete insurance coverage options that proactively deal with the well being issues of people dealing with most cancers.”

Earnings Insurance coverage chief buyer officer Earnings Dhiren Amin mentioned: “To allay some fears in order that they will concentrate on therapy, we’re happy to accomplice with a like-minded firm, Swiss Re, to supply a holistic most cancers proposition that gives full care, from most cancers prognosis to restoration.

“Being the primary in Singapore with a assured post-cancer cowl possibility, we hope to construct our clients’ resilience to recuperate and stay the fulfilling life they wished, when their therapy is over.”

Earlier this month, Swiss Re reported a ninefold enhance in H1 internet revenue to $1.4bn.